Iconic Labs PLC
22 September 2022
Iconic Labs Plc - In Administration ("Iconic Labs" or the "Company")
Notice of Results of Creditors Meeting and General Meeting of Shareholders
Iconic Labs Plc (LSE:ICON hereby advises that it held a general meeting ("GM") earlier today.
The CVA Proposal was approved by the requisite majorities of the creditors at a meeting of the creditors held today at 11am.
At a meeting of the shareholders of the Company, held today at 2.00pm, all resolutions were duly passed on a poll vote.
Details of the proxy voting are shown in the table below.
Votes For | % | Votes Against | % | Votes Total | Votes Withheld | |
Ordinary resolutions: | ||||||
(1) Approval of the Company Voluntary Arrangement ("CVA") . | 10,009,834,608 | 97.49 | 257,331,813 | 2.51 | 10,267,166,421 | 48,068,796 |
(2) To empower the directors to generally allot relevant equity securities in respect of the CVA | 10,240,735,765 | 99.74 | 26,430,656 | 0.26 | 10,267,166,421 | 48,068,796 |
(3) To empower the directors to generally allot relevant equity securities to promote the success of the Company | 10,240,225,765 | 99.74 | 26,430,656 | 0.26 | 10,266,656,421 | 48,578,796 |
Special resolutions: | ||||||
(4) Subject to the passing of Resolution 2, to disapply the pre-emptive rights in respect of the relevant equity securities to be allotted in respect of CVA Proposal . | 10,009,324,608 | 97.49 | 257,331,813 | 2.51 | 10,266,656,421 | 48,578,796 |
(5) Subject to the passing of Resolution 3, to disapply the pre-emptive rights in respect of the relevant equity securities to be allotted to promote the success of the Company. | 10,240,225,765 | 99.74 | 26,430,656 | 0.26 | 10,266,656,421 | 48,578,796 |
The full text of each of the resolutions is set out in the Notice of AGM, available on the Company's website (www.iconiclabs.co.uk).
Market Abuse Regulation (MAR) Disclosure - Certain information contained in this announcement would have been deemed inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 until the release of this announcement.
For further information, please visit the Company's website www.iconiclabs.co.uk or contact the Company via [email protected] .
END